薬剤比較
Vildagliptin vs Lixisenatide
Vildagliptin vs Lixisenatide: Oral DPP-4 vs injectable GLP-1 for T2DM. Weigh A1C control, GI side effects, weight loss, and injection vs pill convenience.
このページには比較できる項目がありません。
臨床的背景
This comparison is triggered when selecting between an oral DPP-4 inhibitor and an injectable GLP-1 agonist for type 2 diabetes patients needing better glycemic control or weight management.
結論
Lixisenatide typically offers stronger A1C reduction and weight loss while Vildagliptin provides oral convenience with a milder GI side-effect profile.
すべての薬剤比較